William E. Rote Travere Therapeutics, Inc. (TVTX) insider trading activity

William E. Rote is Chief Research Officer of Travere Therapeutics, Inc.. Currently has a direct ownership of 101,443 shares of TVTX, which is worth approximately $3.5 Million. The most recent transaction as insider was on Jan 10, 2022, when has been sold 5,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 101K

1.2% 3M change

20.11% 12M change

Total Value Held $3.5 Million

WILLIAM E. ROTE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2022	BUY Grant, award, or other acquisition	-	5,000 Added 10.89%	40,895 Common Stock
Aug 17 2021	SELL Open market or private sale	$24,088 $17.12 p/Share	1,407 Reduced 3.79%	35,731 Common Stock
Aug 13 2021	BUY Grant, award, or other acquisition	-	4,500 Added 10.81%	37,138 Common Stock
May 12 2021	SELL Open market or private sale	$30,397 $19.46 p/Share	1,562 Reduced 4.7%	31,707 Common Stock
May 11 2021	SELL Open market or private sale	$29,916 $19.14 p/Share	1,563 Reduced 4.49%	33,269 Common Stock
Feb 18 2021	SELL Open market or private sale	$35,838 $28.67 p/Share	1,250 Reduced 3.46%	34,832 Common Stock
Feb 17 2021	SELL Open market or private sale	$34,188 $27.35 p/Share	1,250 Reduced 3.35%	36,082 Common Stock

Feb 08 2021	SELL Open market or private sale	$71,055 $31.58 p/Share	2,250 Reduced 5.68%	37,332 Common Stock
Feb 05 2021	SELL Open market or private sale	$70,672 $31.41 p/Share	2,250 Reduced 5.38%	39,582 Common Stock
Feb 03 2021	SELL Open market or private sale	$104,799 $28.91 p/Share	3,625 Reduced 8.85%	37,332 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	4,500 Added 9.71%	41,832 Common Stock
Feb 02 2021	SELL Open market or private sale	$111,469 $30.75 p/Share	3,625 Reduced 7.7%	43,457 Common Stock
Jan 31 2021	BUY Grant, award, or other acquisition	-	5,000 Added 10.08%	44,582 Common Stock
Jan 21 2021	BUY Grant, award, or other acquisition	-	15,000 Added 27.48%	39,582 Common Stock
Nov 16 2020	SELL Open market or private sale	$59,900 $23.96 p/Share	2,500 Reduced 9.4%	24,086 Common Stock
Nov 13 2020	SELL Open market or private sale	$59,050 $23.62 p/Share	2,500 Reduced 8.6%	26,586 Common Stock
Nov 11 2020	BUY Grant, award, or other acquisition	-	5,000 Added 14.67%	29,086 Common Stock

WER

William E. Rote

Chief Research Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TVTX shares.

Notify only if

Value

Insider Trading

Get notified when an Travere Therapeutics, Inc. insider buys or sells TVTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Travere Therapeutics, Inc.

Track Activities on TVTX

Account